Gossamer Bio Inc (NASDAQ: GOSS) kicked off on Monday, down -6.23% from the previous trading day, before settling in for the closing price of $2.57. Over the past 52 weeks, GOSS has traded in a range of $0.66-$3.60.
Healthcare Sector giant saw their annual sales surged by 40.29% over the last five years. While this was happening, its average annual earnings per share was recorded -170.00%. With a float of $181.40 million, this company’s outstanding shares have now reached $227.32 million.
Gossamer Bio Inc (GOSS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Gossamer Bio Inc is 19.65%, while institutional ownership is 61.58%. The most recent insider transaction that took place on Aug 19 ’25, was worth 50,016. In this transaction Director of this company bought 26,050 shares at a rate of $1.92, taking the stock ownership to the 58,050 shares.
Gossamer Bio Inc (GOSS) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.14 earnings per share (EPS), higher than consensus estimate (set at -0.14) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -170.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.09% during the next five years compared to 40.29% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Take a look at Gossamer Bio Inc’s (GOSS) current performance indicators. Last quarter, stock had a quick ratio of 4.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Analysing the last 5-days average volume posted by the [Gossamer Bio Inc, GOSS], we can find that recorded value of 4.03 million was better than the volume posted last year of 2.38 million. As of the previous 9 days, the stock’s Stochastic %D was 15.49%.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 54.44%, which indicates a significant increase from 8.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.22 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.47, while its 200-day Moving Average is $1.48. Now, the first resistance to watch is $2.56. This is followed by the second major resistance level at $2.71. The third major resistance level sits at $2.83. If the price goes on to break the first support level at $2.29, it is likely to go to the next support level at $2.17. Now, if the price goes above the second support level, the third support stands at $2.02.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
The company with the Market Capitalisation of 547.99 million has total of 227,381K Shares Outstanding. Its annual sales at the moment are 114,700 K in contrast with the sum of -56,530 K annual income. Company’s last quarter sales were recorded 11,490 K and last quarter income was -38,270 K.
